comparemela.com

Latest Breaking News On - மருந்துகள் கட்டுப்பாடு அதிகாரம் - Page 4 : comparemela.com

COVID-19: Zim company cashes in on Ivermectin

COVID-19: Zim company cashes in on Ivermectin NewsDay 1 day ago BY PHYLLIS MBANJE The growing interest in the use of Ivermectin to treat and prevent COVID-19 has opened floodgates, with some individuals and companies now advertising the sale of the drug without approval from the Medicines Control Authority of Zimbabwe (MCAZ). © Soumyabrata Roy/NurPhoto via Getty Images FILE - This picture shows the tablets of Ivermectin drugs in Tehatta, West Benga, India on 19 May on 2021. Following a cautionary approval by the regulatory body, which, however, clearly stated that there had been no conclusive evidence yet to support its use, there has been a flurry of activities around the drug.

Zimbabwe to allow use of parasite drug for Covid-19 research

To view all features and options, click here. A monthly subscription is charged pro rata, based on the day of purchase. This is non-refundable and includes a R5 once-off sign-up fee. A yearly subscription is refundable within 14 days of purchase and includes a 365-day membership. The use of the medicine will be limited to gathering information on whether patients are “obtaining clinical benefits” from it in the management of Covid-19 cases, the Medicines Control Authority of Zimbabwe said in a statement posted on its Twitter account. “Data obtained from use of ivermectin in Zimbabwe will be critical in monitoring the safety and efficacy of ivermectin within the Zimbabwean population,” the authority said.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.